Acasti Pharma Inc – Class A (NASDAQ:ACST) Shorts Reduced By 0.55%

April 17, 2018 - By Michele Cranor

Acasti Pharma Inc. (NASDAQ:ACST) Corporate Logo

It was reported a decrease on Acasti Pharma Inc – Class A (NASDAQ:ACST)’s short interest with 0.55%. FINRA announced short interest of ACST’s total 269,900 shares. That’s 0.55% down from 271,400 shares. Acasti Pharma Inc – Class A (NASDAQ:ACST) has 121,900 shares average volume. It’ll cost 2 days for ACST to restore its previous position. 2.49% is Acasti Pharma Inc – Class A float short.

$1.1 was the last price.It’s downtrending since April 17, 2017 and is 21.09% down. ACST underperformed by 32.64% the S&P500.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases.The company has $27.79 million market cap. The company's lead product candidate is CaPre, an omega-3 phospholipid for the treatment of hypertriglyceridemia.Last it reported negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: